Results
The mean age of the participants was 36.0 ± 13.2, with total participants having a percentage of males (52.8%) and females (47.2%), a body mass index less than 18, and a body weight of 48.7 ± 8.6. Neurological examination assessments in participants found normal motor (50%) and normal sensory functions (47.2%). The data were then tested using the Kolmogorov–Smirnov method to determine the distribution of data normality. The test results showed normally distributed data (In the comparison of each group before and after supplementation, obtained at week 4, the difference in TLR-2 levels at doses of 400 IU and 5,000 IU was not significant. At week 8, there were significant differences in TLR-2 levels between the groups (Fig. The concentration of TLR-2 and TLR-4The difference in TLR-4 levels at doses of 400 IU and 5000 IU was not significant. At week 4, there was a significant difference in TLR-4 levels in the 10,000 IU dose group versus the other groups. (Fig. After 4 and 8 weeks of intervention, there were significant differences in vitamin D levels in the three groups. In the 400 IU dose group, the vitamin D levels did not increase significantly through repeated ANOVA from week 0 to week 4 (from 28.38 ± 6.51 ng/ml to 27.62 ± 6,54 ng/mL, = 0.76, 